(Q39421912)

11 September 2017

Morphine or oxycodone in cancer pain? (English)

1 reference

11 September 2017

1 reference

T E Heiskanen

1

1 reference

11 September 2017

P M Ruismäki

series ordinal

2

1 reference

11 September 2017

T A Seppälä

series ordinal

3

1 reference

11 September 2017

E A Kalso

series ordinal

4

1 reference

11 September 2017

1 January 2000

1 reference

11 September 2017

1 reference

11 September 2017

39

1 reference

11 September 2017

941-947

1 reference

11 September 2017

8

1 reference

Pharmacologic treatment of cancer pain

11 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F02841860050215927

An update on the clinical use of methadone for cancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860050215927

Controlled-release oxycodone and morphine in cancer related pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860050215927

Intravenous morphine and oxycodone for pain after abdominal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860050215927

Morphine and oxycodone hydrochloride in the management of cancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860050215927

Determination of Oxycodone in Plasma and Identification of a Major Metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860050215927

The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860050215927

Oral morphine in cancer pain: influences on morphine and metabolite concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860050215927

Systematic review of factors affecting the ratios of morphine and its major metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860050215927

Pharmacokinetics and analgesic effect of slow-release oral morphine sulphate in volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860050215927

Effect of food on the comparative pharmacokinetics of modified-release morphine tablet formulations: Oramorph SR and MST Continus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860050215927

Single-dose and steady-state pharmacokinetics and pharmacodynamics of oxycodone in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860050215927

Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860050215927

Pharmacokinetics of controlled release morphine (MST) in patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860050215927

Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860050215927

10.1080/02841860050215927

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference